JORFX
Price
$19.92
Change
-$0.02 (-0.10%)
Updated
Sep 20 closing price
RWIBX
Price
$66.87
Change
-$0.15 (-0.22%)
Updated
Sep 20 closing price
Ad is loading...

JORFX vs RWIBX

Header iconJORFX vs RWIBX Comparison
Open Charts JORFX vs RWIBXBanner chart's image
Janus Henderson Global Select I
Price$19.92
Change-$0.02 (-0.10%)
VolumeN/A
CapitalizationN/A
American Funds Capital World Gr&Inc R2
Price$66.87
Change-$0.15 (-0.22%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
JORFX vs RWIBX Comparison Chart
Loading...
VS
JORFX vs. RWIBX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JORFX is a Buy and RWIBX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 128B vs. JORFX (2.88B). RWIBX pays higher dividends than JORFX: RWIBX (1.05) vs JORFX (0.91). JORFX was incepted earlier than RWIBX: JORFX (15 years) vs RWIBX (22 years). JORFX is a more actively managed with annual turnover of: 46.00 vs. RWIBX (27.00). RWIBX has a lower initial minimum investment than JORFX: RWIBX (250) vs JORFX (1000000). RWIBX annual gain was more profitable for investors over the last year : 23.75 vs. JORFX (20.50). RWIBX return over 5 years is better than : 42.68 vs. JORFX (38.32).
JORFXRWIBXJORFX / RWIBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years22 years-
Gain YTD18.12813.562134%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.88B128B2%
Annual Yield % from dividends0.911.0587%
Returns for 1 year20.5023.7586%
Returns for 3 years3.637.3749%
Returns for 5 years38.3242.6890%
Returns for 10 years62.4349.04127%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GNFT4.940.75
+17.90%
Genfit SA
NNI112.94-2.01
-1.75%
Nelnet
ILMN131.14-3.25
-2.42%
Illumina
SPRB0.44-0.01
-2.59%
Spruce Biosciences
APLT7.70-0.30
-3.75%
Applied Therapeutics